Twin Focus Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-359
Closed -$386K 188
2025
Q4
$386K Sell
359
-28
-7% -$26.8K 0.04% 149
2025
Q3
$295K Buy
387
+34
+10% +$25.3K 0.04% 155
2025
Q2
$275K Hold
353
0.04% 142
2025
Q1
$292K Sell
353
-65
-16% -$54.1K 0.05% 130
2024
Q4
$323K Sell
418
-150
-26% -$124K 0.05% 119
2024
Q3
$503K Hold
568
0.08% 100
2024
Q2
$514K Sell
568
-50
-8% -$40K 0.08% 92
2024
Q1
$481K Sell
618
-16
-3% -$11.4K 0.09% 94
2023
Q4
$370K Sell
634
-80
-11% -$46.7K 0.08% 103
2023
Q3
$384K Sell
714
-599
-46% -$309K 0.09% 106
2023
Q2
$616K Buy
1,313
+123
+10% +$51.6K 0.12% 99
2023
Q1
$409K Hold
1,190
0.08% 123
2022
Q4
$435K Sell
1,190
-14
-1% -$4.96K 0.09% 113
2022
Q3
$389K Sell
1,204
-133
-10% -$42.1K 0.09% 112
2022
Q2
$433K Sell
1,337
-137
-9% -$41.1K 0.1% 111
2022
Q1
$422K Sell
1,474
-48
-3% -$12.4K 0.08% 127
2021
Q4
$420K Buy
1,522
+77
+5% +$19.5K 0.08% 130
2021
Q3
$334K Sell
1,445
-15
-1% -$3.7K 0.08% 125
2021
Q2
$335K Buy
1,460
+350
+32% +$70.3K 0.08% 131
2021
Q1
$207K Sell
1,110
-80
-7% -$15.6K 0.06% 147
2020
Q4
$201K Buy
+1,190
New +$178K 0.06% 154

Other funds holding LLY

Twin Focus Capital Partners's LLY Position: Q1 2026 in Review

Twin Focus Capital Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 359 shares — an estimated $386K sold.

Twin Focus Capital Partners first reported a position in LLY in Q4 2020 and held it in 21 quarters. The position peaked at $616K in Q2 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Twin Focus Capital Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Twin Focus Capital Partners sold 359 Eli Lilly shares in Q1 2026, an estimated $386K.
  • Twin Focus Capital Partners first reported a position in Eli Lilly in Q4 2020 and held it in 21 quarters.
  • Twin Focus Capital Partners's Eli Lilly position peaked at $616K in Q2 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Twin Focus Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.